期刊文献+

脂质体-C-erbB_2反义寡核苷酸对人卵巢上皮癌裸鼠皮下移植瘤的作用 被引量:6

Effects of liposome C erbB 2 antisense oligodeoxynucleotides on the human ovarian epithelial cancer transplanted subcutaneously in nude mice.
下载PDF
导出
摘要 目的:探讨经脂质体—硫代磷酸化修饰的C-erbB2反义脱氧寡核苷酸(C-erbB2sulfide-ODNs)作用后的卵巢上皮癌细胞在裸鼠皮下的成瘤能力及形态学变化。方法:利用离体途径将C-erbB2sulfide-ODNs导入卵巢上皮癌细胞,然后接种于裸鼠皮下,观察肿瘤体积的变化,并计算抑瘤率。用透射电镜观察肿瘤形态变化。结果:经脂质体-C-erbB2sulfide-ODNs作用后的卵巢上皮癌细胞在裸鼠皮下成瘤能力降低,最大抑瘤率可达41.7%。超微结构显示实验组肿瘤细胞异染色质增多,分化增高。结论:C-erbB2癌基因的反义调控能降低卵巢上皮癌的成瘤能力,抑制肿瘤生长。 Objective:To investigate the effects of liposome C erbB 2 antisense phosphorothioate oligodeoxynucleotides(sulfide ODNs)on the human ovarian epithelial cancer transplanted subcutaneously in nude mice.Methods:Human ovarian epithelial cancer cells SKOV 3 were treated with liposome C erbB 2 sulfide ODNs,then transplanted subcutaneously in the nude mice.The changes of tumor volume were observed and the growth inhibitory rate was calculated.The morphologic changes were observed by electromicroscope.Results:The tumorigenic ability of the treated cells was reduced.The tumor growth inhibitory rate was about 41.7%.The tumor cells treated with liposome C erbB 2 sulfide ODNs had more heterochromatin than that in the control cells,and differentiated better.Conclusion:The results suggest that C erbB 2 antisense therapy can inhibit the tumorigensis of ovarian epithelial cancer cells in nude mice.It may be a useful gene therapy for the ovarian epithelial cancer.
出处 《现代妇产科进展》 CSCD 1998年第4期314-316,共3页 Progress in Obstetrics and Gynecology
基金 国家自然科学基金
关键词 脂质体 C-ERBB2 寡核苷酸类 卵巢上皮肿瘤 Liposome C erbB 2 Oligonucleotides,antisense Ovarian epithelial neoplasms Mice,nude
  • 相关文献

同被引文献44

  • 1杨静平,孔玉英.SA脂质体—高效介导DNA转染的新试剂[J].生物化学与生物物理学报,1993,25(3):231-238. 被引量:15
  • 2吴令英,吴爱如,姜琨,侯萍,王秀琴,孙建衡.c-erbB2反义核酸对卵巢癌细胞系生物学行为及药物敏感性的影响[J].中华妇产科杂志,1996,31(3):169-172. 被引量:4
  • 3Wadler S. New developments in treatment of ovarian cancer [J].Expert Opin Investig Drugs, 2001, 10(6): 1167 - 1172.
  • 4Harries M, Kaye SB. Recent advances in the treatment of epithelial ovarian cancer [J]. Expert Opin lnvestig Drugs, 2001,10(9): 1715 - 1724.
  • 5Ozols Robert F. Future directions in the treatment of ovarian cancer [ J ]. Semin Oncol, 2002, 29 ( 1 suppl ) : 32 - 42.
  • 6Kronenwett R. Hass R. Antisense strategies for the treatment of hematological malignancies and solid tumors [J] . Ann Hematol,1998,77(1 -2): 1 - 12.
  • 7Guha C, Guha U. Tribius S, et al. Antisense ATM gene therapy: a strategy to increase the radiosensitivity of human tumors [J]. Gene Ther, 2000, 7( 10): 852 - 858.
  • 8Pietras K, Ostman A, Sjoquist M, et al. Inhibition of platelet-derived Growth Factor Receptor reduces interstitial hypertension and increase transcapillary transport in tumor [J].Cancer Res, 2001, 61 (7): 2929 - 2934.
  • 9King BI, Carter D, Foellmer HG, et al. Neu proto-oncogene amplification and expression in overian adenocarcinoma cell lines[J]. Am J pathol, 1992,140(1):23-31.
  • 10Funato T, Kozawa K, Fujimaki S, et al. Increased sensitivity to cisplatin in gastric cancer by antisense inhibition of the HER-2/neu(C-erbB-2) Gene [J]. Chemotherapy, 2001, 47(4): 297-303.

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部